Suppr超能文献

可注射凝胶递药系统治疗颌骨感染。

Injectable gelling delivery system for the treatment of jawbone infections.

机构信息

Department of Pharmacy Sciences, School of Pharmacy & Health Professions, Creighton University, Omaha, NE 68178, USA.

出版信息

Ther Deliv. 2021 Nov;12(11):775-788. doi: 10.4155/tde-2021-0054. Epub 2021 Nov 22.

Abstract

A polymeric gelling delivery system for localized and sustained delivery to jawbone infections was developed. gelling delivery systems were prepared using either Poly(dl-lactic acid) or chitosan and Pluronic F127/Pluronic F68. Metronidazole nanoparticles were prepared using poly(dl-lactide-co-glycolide) or chitosan. Poly(dl-lactide-co-glycolide) was used for microparticles. Particles were characterized for size, charge and morphology. Viscosity and yield stress of the gels were 0.4 Pa.s and 2 Pa, respectively, with 70% cell viability over 72 h. Around 90% of loaded metronidazole was released at a sustained rate over 1 week. Use of appropriate amount of nano/microparticles in the gel resulted in a sustained release over a period of 1 week - needed for jawbone infection.

摘要

一种用于颌骨感染的局部和持续递药的聚合胶态输送系统被开发出来。胶态输送系统是使用聚(DL-丙交酯)或壳聚糖和泊洛沙姆 F127/泊洛沙姆 F68 制备的。甲硝唑纳米颗粒是使用聚(DL-丙交酯-共-乙交酯)或壳聚糖制备的。聚(DL-丙交酯-共-乙交酯)用于制备微球。对颗粒的粒径、电荷和形态进行了表征。凝胶的粘度和屈服应力分别为 0.4 Pa.s 和 2 Pa,72 h 内细胞活力保持在 70%以上。大约 90%的负载甲硝唑以持续速率释放超过 1 周。在凝胶中使用适量的纳米/微颗粒可实现长达 1 周的持续释放-这是颌骨感染所需要的。

相似文献

1
Injectable gelling delivery system for the treatment of jawbone infections.可注射凝胶递药系统治疗颌骨感染。
Ther Deliv. 2021 Nov;12(11):775-788. doi: 10.4155/tde-2021-0054. Epub 2021 Nov 22.
3
In situ forming polymeric drug delivery systems.原位形成聚合物药物递送系统
Indian J Pharm Sci. 2009 May;71(3):242-51. doi: 10.4103/0250-474X.56015.

引用本文的文献

1
Advances in drug delivery systems, challenges and future directions.药物递送系统的进展、挑战与未来方向。
Heliyon. 2023 Jun 24;9(6):e17488. doi: 10.1016/j.heliyon.2023.e17488. eCollection 2023 Jun.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验